My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 226

    1.

    Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients.

    Raji A, Seely EW, Bekins SA, Williams GH, Simonson DC.

    Diabetes Care. 2003 Jan;26(1):172-8.PMID: 12502676 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.

    Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN.

    J Hypertens. 2004 Sep;22(9):1769-77.PMID: 15311106 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

    Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

    Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

    Diabetes. 2003 Aug;52(8):1943-50.PMID: 12882909 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

    Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.PMID: 16487914 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.

    Dorella M, Giusto M, Da Tos V, Campagnolo M, Palatini P, Rossi G, Ceolotto G, Felice M, Semplicini A, Del Prato S.

    J Clin Endocrinol Metab. 1996 Apr;81(4):1568-74.PMID: 8636369 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.

    Schneider F, Vossler S, Franke S, Bär F, Konrad T.

    Int J Clin Pharmacol Ther. 2009 May;47(5):311-20.PMID: 19473593 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance.

    Bennett SM, Agrawal A, Elasha H, Heise M, Jones NP, Walker M, Wilding JP.

    Diabet Med. 2004 May;21(5):415-22.PMID: 15089784 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Anti-hypertensive effect of rosiglitazone in non-diabetic essential hypertension]

    Li GW, Wang JP, Li CM, Chen YY, Yang WY, Xing XY, Liu KL, Tang YL, Li H.

    Zhonghua Nei Ke Za Zhi. 2004 Dec;43(12):907-10. Chinese. PMID: 15730735 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.

    Tarkun I, Cetinarslan B, Türemen E, Sahin T, Cantürk Z, Komsuoglu B.

    Eur J Endocrinol. 2005 Jul;153(1):115-21.PMID: 15994753 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

    Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA.

    Diabetologia. 2001 Dec;44(12):2210-9.PMID: 11793023 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.

    Tomazic J, Karner P, Vidmar L, Maticic M, Sharma PM, Janez A.

    Acta Dermatovenerol Alp Panonica Adriat. 2005 Sep;14(3):99-105.PMID: 16200335 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

    Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW.

    Fertil Steril. 2003 Mar;79(3):562-6.PMID: 12620440 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

    Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K.

    Am J Hypertens. 1995 Mar;8(3):316-20.PMID: 7794582 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.

    Sarafidis PA, Lasaridis AN, Nilsson PM, Mouslech TF, Hitoglou-Makedou AD, Stafylas PC, Kazakos KA, Yovos JG, Tourkantonis AA.

    Metabolism. 2005 Sep;54(9):1236-42.PMID: 16125536 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.

    Yosefy C, Magen E, Kiselevich A, Priluk R, London D, Volchek L, Viskoper RJ Jr.

    J Cardiovasc Pharmacol. 2004 Aug;44(2):215-22.PMID: 15243303 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity